Skip to main content
Equibles
DXR logo

DXR · Daxor Corp · Metrics

Track DXR — free

Use DXR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DXR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.63 +0.01 (+0.09%) At close · Oct 5
Rebalance outlook locked
Market Cap
$44.52M
Shares
4.20M
Volume · Oct 5 30.32K Avg daily vol (3M) 18.46K

DXR metrics

46 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.62
Market cap
$44.52M

Price action

20 metrics
Price change (1W)
-3.5%
Price change (30D)
+1.5%
Price change (3M)
+2.3%
Price change (6M)
+9.5%
Price change (YTD)
-28.0%
Price change (1Y)
-24.1%
Trailing year
Price change (5Y)
-5.6%
52-week high
$14.75
52-week low
$8.87
Change from 52-week high
-28.0%
Change from 52-week low
+19.7%
Annualized volatility
52.0%
Annualized volatility (3M)
—
Beta
0.0
RSI (14D)
45.6
Price vs SMA 50
-0.7%
Price vs SMA 200
-5.4%
Avg volume (3M)
18,463
Relative volume
0.5
Average dollar volume
$206,093

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
4.20M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.2
reciprocal yield 81.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2024-12-31

Profitability

9 metrics
Gross margin
54.9%
Operating margin
-400.1%
Trailing 12 months
Net margin
-496.8%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$8.62

Growth

11 metrics
Revenue growth YoY
-24.8%
Year over year
Net income growth YoY
-260.6%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-0.6%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-19.8%
Return on assets
-8.4%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$59,625
Latest balance sheet
Cash & equivalents
$59,625
Total assets
$85.72M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
15
13F filer change QoQ
0
Institutional ownership
10.1%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
44 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 27367 CUSIP 239467103 Visit website Investor relations